Lymph node targeted multi epitope subunit vaccine promotes effective immunity to EBV in HLA expressing mice Nature Communications Palivizumab (Synagis) is a short acting monoclonal antibody for the prevention of RSV disease in certain high risk infants. It is given as a series of 5 monthly injections during an RSV season. With Anticorps monoclonaux : quel est ce nouveau traitement anti Covid, voqu par Olivier Vran ? midilibre.fr Today, we expanded our partnership with Sanofi Healthcare India Private Limited (SHIPL) to launch Beyfortus (nirsevimab), a novel drug for preventing Respiratory Syncytial Virus (RSV) in India. RSV is a highly contagious COVID 19 and Vaccines and mABs, Oh My! NephJC Applications et thrapeutique des anticorps monoclonaux (mAb)